RESMED INC — Director's Dealing 2015

Feb 6, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-02-04

Reporting Person: WAREHAM JOHN P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-04	ResMed Common Stock	M	36000	$25.54	Acquired	49000	Direct
2015-02-04	ResMed Common Stock	S	36000	$63.489	Disposed	13000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-04	ResMed Common Stock Options	$25.54	M	36000	Acquired	2016-12-17	ResMed Commmon Stock (36000)	Direct

Footnotes

F1: Represents date options became fully vested. These options cliff vested on the first November 11 following the grant date.

F2: This transaction was executed in multiple trades at prices ranging from $63.37 to $63.49. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.